Karachi: In a significant corporate development, Landmark Spinning Industries Limited announced the successful completion of its reverse merger with Liven Pharmaceuticals Pvt. Ltd., according to a statement released on September 2, 2024. The merger, which was sanctioned by the High Court of Sindh at Karachi, aims to amalgamate the entire businesses and undertakings of both entities into a single operational unit.

According to information available from the Pakistan Stock Exchange (PSX), this merger marks a pivotal transformation for Landmark Spinning Industries, enabling it to diversify its business operations and enhance its market standing. The joint petition for the merger was filed earlier and has received official approval, setting the stage for the combined entity to commence operations immediately as a merged entity.

The Chairman of Landmark Spinning Industries expressed satisfaction with the merger's completion and highlighted the company's commitment to maintaining rigorous compliance with legal requirements and transparency in its operations. The board, inclusive of non-executive and independent directors, plays a crucial role in ensuring effective corporate governance, which is pivotal in navigating the complex challenges faced by the company in the current economic climate.

Pakistan continues to confront various internal and external challenges, including political extremism and economic instability, which have impacted the business environment. The merger is seen as a strategic move to strengthen Landmark Spinning’s capabilities to withstand these pressures and leverage synergies between textile manufacturing and pharmaceutical production.

In his statement, the Chairman thanked the customers, suppliers, and shareholders for their unwavering support and underscored the employees' dedication to the company during these transformative times.